94 related articles for article (PubMed ID: 23604870)
1. APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective.
Tai LM; Ghura S; Koster KP; Liakaite V; Maienschein-Cline M; Kanabar P; Collins N; Ben-Aissa M; Lei AZ; Bahroos N; Green SJ; Hendrickson B; Van Eldik LJ; LaDu MJ
J Neurochem; 2015 May; 133(4):465-88. PubMed ID: 25689586
[TBL] [Abstract][Full Text] [Related]
2. LRPAP1 is released from activated microglia and inhibits microglial phagocytosis and amyloid beta aggregation.
Reid KM; Brown GC
Front Immunol; 2023; 14():1286474. PubMed ID: 38035103
[TBL] [Abstract][Full Text] [Related]
3. ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis.
Staurenghi E; Leoni V; Lo Iacono M; Sottero B; Testa G; Giannelli S; Leonarduzzi G; Gamba P
Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358540
[TBL] [Abstract][Full Text] [Related]
4. PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer's Disease.
Papotti B; Adorni MP; Marchi C; Zimetti F; Ronda N; Panighel G; Lupo MG; Vilella A; Giuliani D; Ferri N; Bernini F
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293049
[TBL] [Abstract][Full Text] [Related]
5. The New Frontiers in Neurodegenerative Diseases Treatment: Liposomal-Based Strategies.
Cascione M; De Matteis V; Leporatti S; Rinaldi R
Front Bioeng Biotechnol; 2020; 8():566767. PubMed ID: 33195128
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing Neuroinflammation via the JNK/c-Jun Pathway in the Early Phase of Experimental Subarachnoid Hemorrhage in Mice.
Wu Y; Pang J; Peng J; Cao F; Guo Z; Jiang L; Teng Z; Huang Z; Cheng C; Jiang Y; Sun X
Oxid Med Cell Longev; 2019; 2019():3832648. PubMed ID: 31949876
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease.
Binda A; Panariti A; Barbuti A; Murano C; Dal Magro R; Masserini M; Re F; Rivolta I
Int J Nanomedicine; 2018; 13():4059-4071. PubMed ID: 30034232
[TBL] [Abstract][Full Text] [Related]
8. Neurometabolic roles of ApoE and Ldl-R in mouse brain.
Lee J; Choi J; Wong GW; Wolfgang MJ
J Bioenerg Biomembr; 2016 Feb; 48(1):13-21. PubMed ID: 26686234
[TBL] [Abstract][Full Text] [Related]
9. Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain.
Tamaru M; Akita H; Nakatani T; Kajimoto K; Sato Y; Hatakeyama H; Harashima H
Int J Nanomedicine; 2014; 9():4267-76. PubMed ID: 25228805
[TBL] [Abstract][Full Text] [Related]
10. More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration.
Lane-Donovan C; Philips GT; Herz J
Neuron; 2014 Aug; 83(4):771-87. PubMed ID: 25144875
[TBL] [Abstract][Full Text] [Related]
11. A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.
Spencer B; Verma I; Desplats P; Morvinski D; Rockenstein E; Adame A; Masliah E
J Biol Chem; 2014 Jun; 289(25):17917-31. PubMed ID: 24825898
[TBL] [Abstract][Full Text] [Related]
12. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
Kanekiyo T; Xu H; Bu G
Neuron; 2014 Feb; 81(4):740-54. PubMed ID: 24559670
[TBL] [Abstract][Full Text] [Related]
13. Absence of selenoprotein P but not selenocysteine lyase results in severe neurological dysfunction.
Raman AV; Pitts MW; Seyedali A; Hashimoto AC; Seale LA; Bellinger FP; Berry MJ
Genes Brain Behav; 2012 Jul; 11(5):601-13. PubMed ID: 22487427
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein facilitates in vivo delivery of α-tocopherol-conjugated short-interfering RNA to the brain.
Uno Y; Piao W; Miyata K; Nishina K; Mizusawa H; Yokota T
Hum Gene Ther; 2011 Jun; 22(6):711-9. PubMed ID: 21166521
[TBL] [Abstract][Full Text] [Related]
15. Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons.
Gong JS; Morita SY; Kobayashi M; Handa T; Fujita SC; Yanagisawa K; Michikawa M
Mol Neurodegener; 2007 May; 2():9. PubMed ID: 17504523
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: A review.
Fan QW; Iosbe I; Asou H; Yanagisawa K; Michikawa M
J Am Aging Assoc; 2001 Jan; 24(1):1-10. PubMed ID: 23604870
[TBL] [Abstract][Full Text] [Related]
17. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
Tacken PJ; Beer FD; Vark LC; Havekes LM; Hofker MH; Willems Van Dijk K
Biochem J; 2000 Apr; 347(Pt 2):357-61. PubMed ID: 10749663
[TBL] [Abstract][Full Text] [Related]
18. The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease.
Lane-Donovan C; Herz J
J Lipid Res; 2017 Jun; 58(6):1036-1043. PubMed ID: 28292942
[TBL] [Abstract][Full Text] [Related]
19. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
